Responding to the COVID-19 outbreak: global clinical performance and development of the Applied Biosystems TaqPath COVID-19 Assay

As the world continues to contend with the SARS-CoV-2 outbreak, Thermo Fisher Scientific continues to arm laboratories with the widest, most innovative selection of COVID-19 testing solutions that meet the needs of the communities in which they operate. From the initial launch in January to Emergency Use Authorization and global approvals in March to subsequent developments to enable more laboratories to do more testing, our kit has become a central component of many COVID-19 protocols around the world. In this workshop, some of those laboratories will share clinical data and discuss how our solutions are helping in the fight against SARS-CoV-2.


Peter Silvester  Paul Granato

• Peter Silvester, Senior Vice President, Thermo Fisher Scientific
• Paul Granato, PhD, Director of Microbiology, Laboratory Alliance of Central New York

Applied Biosystems TaqPath COVID-19 Combo Kit: For Emergency Use Authorization (EUA) only. For prescription use only. For in vitro diagnostic use.

(*Indicates a mandatory field)

This product is only available to clinical laboratories conducting testing for COVID-19. Regulations prohibit us from providing this product to individual customers.